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Abstract
Background and Purpose—White matter hyperintensities (WMH) are increased in patients with lacunar
stroke. Whether this is because of shared pathogenesis remains unknown. Using genetic data, we
evaluated whether WMH-associated genetic susceptibility factors confer risk of lacunar stroke, and
therefore whether they share pathogenesis.
Methods—We used a genetic risk score approach to test whether single nucleotide polymorphisms
associated with WMH in community populations were associated with magnetic resonance imaging–
confirmed lacunar stroke (n=1,373), as well as cardioembolic (n=1,331) and large vessel (n=1,472) Trial
of Org 10172 in Acute Stroke Treatment subtypes, against 9,053 controls. Second, we separated
lacunar strokes into those with WMH (n=568) and those without (n=787) and tested for association with
the risk score in these 2 groups. In addition, we evaluated whether WMH-associated single nucleotide
polymorphisms are associated with lacunar stroke, or in the 2 groups.
Results—The WMH genetic risk score was associated with lacunar stroke (odds ratio [OR; 95%
confidence interval [CI]]=1.14 [1.06–1.22]; P=0.0003), in patients both with and without WMH (WMH: OR
[95% CI]=1.15 [1.05–1.26]; P=0.003 and no WMH: OR [95% CI]=1.11 [1.02–1.21]; P=0.019).
Conversely, the risk score was not associated with cardioembolic stroke (OR [95% CI]=1.03 [0.97–1.09];
P=0.63) or large vessel stroke (OR [95% CI]=0.99 [0.93,1.04]; P=0.39). However, none of the WMH-
associated single nucleotide polymorphisms passed Bonferroni-corrected significance for association
with lacunar stroke.
Conclusions—Genetic variants that influence WMH are associated with an increased risk of lacunar
stroke but not cardioembolic or large vessel stroke. Some genetic susceptibility factors seem to be
shared across different radiological manifestations of small vessel disease.
cerebral small vessel diseases genetics genetic association studies
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Introduction
Cerebral small vessel disease (SVD) affects the small perforating arteries of the brain and is
characterized radiologically by several features, including white matter hyperintensities (WMH),
subcortical lacunar infarcts, intracerebral hemorrhages, and cerebral microbleeds.  Despite the
considerable impact of SVD on health through increased risk of stroke and vascular dementia, the
pathophysiological mechanisms underlying SVD remain largely unknown. Pathological findings in
diseased vessels include lipohyalinosis and microatheroma,  whereas in the parenchyma findings
include myelin pallor, enlargement of perivascular spaces, and gliosis.  Many of these findings are
common to both WMH and lacunar stroke.  However, pathological studies have been hampered by
methodological and phenotypic inconsistencies.  In addition, little is known about the extent to which
underlying pathogenesis is shared across the radiological manifestations. WMH are increased in lacunar
stroke ; more so than in other pathological subtypes of stroke, which may indicate that shared
pathological processes underlie the 2. In addition, both confluent WMH and lacunar infarcts are a
common finding in Mendelian forms of SVD such as cerebral autosomal dominant arteriopathy with
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subcortical infarcts and leukoencephalopathy,  although the underlying arterial pathology is considerably
different to that of sporadic SVD. However, aside from these exceptions and shared cardiovascular risk
factors such as hypertension, few molecular processes have been robustly shown to impact on both
lacunar stroke and WMH.
Genetic studies can provide novel insights into SVD and the nature of the relationship between its
manifestations. In particular, genome-wide association studies have recently identified multiple genetic
variants associated with WMH in community-dwelling individuals  and have been used to show that
common variants in COL4A2, a gene associated with monogenic SVD, influence sporadic SVD.  In
addition, genome-wide association studies provide a means of interrogating the relationship between
complex traits and assessing whether such traits share pathogenesis. Polygenic risk score approaches
can be used to investigate whether 2 conditions are genetically related by testing whether the cumulative
effect of trait-associated single nucleotide polymorphisms (SNPs) associated with the first trait influence
a second trait. Such approaches have previously been used to assess the influence of risk factors on
stroke  and to assess the shared susceptibility between stroke and migraine.
In this analysis, we evaluated the impact of common genetic variants associated with WMH from
community populations on the risk of lacunar stroke in a well-characterized population of magnetic
resonance imaging (MRI)–confirmed lacunar stroke cases and controls. As heterogeneity in the
pathology underlying lacunar stroke has been hypothesized,  and to test whether an association with
lacunar stroke was present in individuals without substantial WMH, we separated our lacunar stroke
cases into those with substantial WMH and those with no or mild WMH, testing the influence of WMH-
associated variants on these subgroups, as well as on cardioembolic and large vessel strokes. We first
used a genetic risk score approach to evaluate the overall evidence that WMH-associated variants affect
stroke phenotypes, and then second evaluated whether each of the specific genetic variants is
associated with lacunar stroke in both the groups with and without WMH.
Materials and Methods
Study Participants
The study data set consisted of stroke cases obtained from hospital admissions in the UK and Germany
(DNA-lacunar, Genes and Ischaemic Stroke [GENESIS] and Wellcome Trust Case Control Consortium 2
[WTCCC2] study), Australia (Australian Stroke Genetics Collaborative [ASGC]), Italy (Milano—Besta
Stroke Register [BSR]), and Belgium (Leuven Stroke Study [LSS]), as well as 9053 controls consisting of
ancestry-matched individuals from each of the respective case populations (Table). These data sets
have been described in detail in previous publications.  Genotyping and imputation of the individuals
are described in the online-only Data Supplement. Briefly, all data sets were genotyped on commercially
available Illumina arrays and imputed to 1000 Genomes phase 3 using SHAPEIT v2 (for phasing) and
IMPUTE v2.2.2 (for imputation).
Table.
Association of SNPs Associated With WMH in Lacunar Stroke Phenotypes
Phenotype Classification
Subtyping of the ASGC, WTCCC2, GENESIS, BSR, and LSS groups was initially performed using the
Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification,  using clinical assessment as well
as brain and vascular imaging where available. For this analysis, we considered only cardioembolic,
large vessel, and small vessel subtypes. For the cases that were classified as small vessel stroke under
TOAST and had accompanying MRI, as well as all cases from UK Young Lacunar Stroke Study (DNA-
lacunar) which included only cases with the TOAST SVD subtype, we performed further characterization,
as follows. All MRI scans were centrally reviewed by 1 physician (H.S.M.). The diagnosis of lacunar
stroke was confirmed using the following criteria. Lacunar stroke was defined as a clinical lacunar
syndrome,  with an anatomically compatible lesion on MRI (subcortical infarct ≤15 mm in diameter). For
MRIs performed in the acute phase, the diagnosis was made by an acute lacunar infarct on DWI. For
scans not performed in the acute phase, the diagnosis was made by a lacunar syndrome in combination
with a lacunar infarct visualized on T1 and fluid-attenuated inversion recovery as a cavitated lesion in an
anatomically appropriate location. Exclusion criteria were as follows: stenosis >50% in the extra- or
intracranial cerebral vessels; cardioembolic source of stroke, defined according to the TOAST criteria as
high or moderate probability; subcortical infarct >15 mm in diameter, as these can be caused by embolic
mechanisms (striatocapsular infarcts); any other specific cause of stroke (eg, lupus anticoagulant,
cerebral vasculitis, dissection, monogenic forms of stroke, such as cerebral autosomal dominant
arteriopathy with subcortical infarcts and leukoencephalopathy). For each individual with a lacunar
stroke, we characterized the degree of WMH using the semiquantitative Fazekas scale,  which
classifies individuals into 4 groups ranging from none (0) to severe (3). Based on this grading, we then
divided the lacunar stroke cases into those with and without WMH: (1) no WMH—patients with only mild
or absent leukoaraiosis (Fazekas grade 0 or 1) and (2) WMH—patients with moderate or severe
leukoaraiosis (Fazekas grade ≥2).
Genetic Risk Score Analyses
For each of the 18 SNPs associated with WMH in community populations in a recent study (8 genome-
wide and 10 with P<1×10  in Europeans or overall),  we generated an unweighted risk score for each
individual in our data set by counting the number of risk alleles and summing across all SNPs. We used
an unweighted approach, rather than an approach weighted on the log of the odds ratio (OR), as effect
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sizes were not reported for the published associations with WMH.  Three of the SNPs (rs186314186,
rs150695384, and rs117126031) were rare and not well imputed in our data set so were not included.
Within each data set, we then converted each individual’s risk score to a Z-score using the standard
transformation. We then used logistic regression to estimate the influence of the risk score on each
stroke outcome, including ancestry-informative principal components to control for population
stratification and meta-analyzing the results using a fixed-effects inverse variance weighted approach.
We tested for association of the genetic risk score with lacunar, cardioembolic, and large vessel stroke.
To investigate whether an association with lacunar stroke was independent of WMH, we performed the
same analysis on 2 subgroups of lacunar stroke stratified on the presence of substantial WMH (Fazekas
≥2). As the purpose of this analysis was to identify whether the observed association with lacunar stroke
was independent of WMH, we did not perform the same analyses in the other subtypes. All ORs
reported are per 1 SD change in the normally distributed risk score. We set the criteria for statistical
significance at P<0.01, Bonferroni-correcting for the 5 tests.
Single SNP Analyses
In addition, we tested the association of each of the 15 available SNPs with lacunar stroke and the 2
subgroups based on the presence or absence of WMH. For each SNP we performed analyses
separately in the 3 batches, including the first 10 ancestry-informative principal components in each
analysis. We meta-analyzed the results using a fixed-effects inverse-variance weighted approach. We
set the significance threshold at P<0.0011, correcting for the 15 SNPs in each of the 3 phenotypes (45
tests in total). All analyses were performed using the R statistical software.
Results
Cohort Characteristics
The final cohort consisted of 4176 stroke cases, including 1,373 lacunar stroke cases (mean age
[SD]=60.0 [11.3] years; 68.0% men), subtyped into 568 with WMH (mean age [SD]=65.1 [10.9] years;
65.0% men) and 787 without WMH (mean age [SD]=56.0 [9.9] years; 70.2% men), 1,331 cardioembolic
strokes (mean age [SD]=72.8 [10.6] years; 52.7% men), and 1,472 large vessel strokes (mean age
[SD]=66.9 [11.1] years; 67.3% men) and 9,053 controls (mean age [SD]=58.4 [10.7] years [age not
available in 2437 of WTCCC2-UK controls]; 52.2% men). Information on WMH volumes was not
available in controls. As inclusion in the MRI-informed lacunar stroke analysis depended on the
availability of an MRI and confirmation of a lacunar infarct, proportions of lacunar stroke cases varied
greatly between studies (Figure 1).
Download figure  Open in new tab  Download powerpoint
Figure 1.
Cohort characteristics. ASGC indicates Australian Stroke Genetics Collaborative; CE, cardioembolic
stroke; GENESIS, Genes and Ischaemic Stroke; LSS, Leuven Stroke Study; LVD, large vessel
disease; MRI, magnetic resonance imaging; SVD, small vessel disease; WMH, white matter
hyperintensities; and WTCCC2, Wellcome Trust Case Control Consortium 2.
Genetic Risk Score Analyses
A genetic risk score comprises 15 SNPs associated with WMH in community populations was
significantly associated with lacunar stroke (OR [95% confidence interval [CI]=1.14 [1.06–1.22];
P=0.0003; Figure 2). The association was slightly stronger, although not significantly so, in the group
with WMH (OR [95% CI]=1.15 [1.05–1.26]; P=0.003) and slightly weaker and not reaching Bonferroni-
corrected significance in the group without substantial WMH (OR [95% CI]=1.11 [1.02–1.21]; P=0.019).
Conversely, the risk score was not associated with cardioembolic (OR [95% CI]=1.03 [0.97–1.09];
P=0.39) or large vessel stroke (OR [95% CI]=0.99 [0.93–1.04]; P=0.63).
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Figure 2.
Association of white matter hyperintensities (WMH) Genetic Risk Score with ischemic stroke
subtypes. GENESIS indicates Genes and Ischaemic Stroke; LSS, Leuven Stroke Study; and
MCLSC, magnetic resonance imaging-confirmed lacunar stroke collaboration (Australian Stroke
Genetics Collaborative [ASGC], Wellcome Trust Case Control Consortium 2 [WTCCC2-UK],
Wellcome Trust Case Control Consortium 2 [WTCCC2]-Germany and Milano studies).
Single SNP Analyses
No SNP reached the a priori significance threshold after Bonferroni correction (Table). Four SNPs
(rs7909791[SH3PXD2A], OR [95% CI]=1.14 [1.03–1.27]; P=0.01; rs72934505[NBEAL1], OR [95%
CI]=1.24 [1.07–1.45]; P=0.004; rs941898[EVL], OR [95% CI]=1.12 [1.01–1.25]; P=0.04; and
rs9515201[COL4A2], OR [95% CI]=1.15 [1.03–1.27]; P=0.01) reached a nominal significance threshold
in the all lacunar stroke analysis.
Discussion
We used a genetic risk score approach to determine whether genetic variants associated with WMH
confer risk of lacunar stroke, and therefore whether WMH and lacunar stroke share pathogenesis. We
found strong evidence that genetic variants associated with WMH in community populations also
influence risk of lacunar stroke. This provides further evidence to support the long-held view that
neuroimaging features of cerebral SVD share pathophysiology. When dividing our lacunar stroke
population into those with moderate to severe WMH and those without, we found some evidence for
association with both groups, although the association was marginally (and not significantly) stronger in
the group with WMH and the association in the group without WMH did not reach Bonferroni-corrected
significance. This suggests that variants influencing WMH confer risk of lacunar stroke even for lacunar
strokes without substantial WMH. In addition, 2 of the SNPs, rs9515201[COL4A2] and rs2984613[PMF1-
BGLAP], are also associated with intracerebral hemorrhage.  This serves to emphasize that shared
pathophysiological processes seem to underlie many of the clinical manifestations of cerebral SVD and
suggests that a coordinated attempt to identify cerebral SVD associations will likely be fruitful. Four
SNPs reached nominal significance for association with lacunar stroke (rs7909791[SH3PXD2A],
rs72934505[NBEAL1], rs941898[EVL], and rs9515201[COL4A2]). With the exception of COL4A2, which
has been linked to SVD, none of these loci have formerly been linked to ischemic stroke. As discussed
above, similar arterial changes have been described in patients with lacunar stroke or WMH,  including
diffuse arteriosclerosis and a more focal microatheroma. Other studies have shown that mechanisms
including blood–brain barrier dysfunction,  and endothelial dysfunction,  are important in both.  As
our results show a shared molecular basis to the 2 traits, they might suggest that these findings are
because of the fact that WMH and lacunar stroke are outward manifestations of a shared underlying
pathological process, namely, cerebral SVD.
In contrast, a genetic risk score comprising the same 15 SNPs was not associated with large vessel or
cardioembolic stroke. Some studies have shown a relationship between subclinical atherosclerosis and
WMH,  whereas others have found an increased risk of all stroke in individuals with WMH.  Our
results, in a well-characterized population, suggest that the relationship between WMH and ischemic
stroke is limited to lacunar stroke. This finding might suggest that previously reported associations
between nonlacunar strokes and WMH may be because of shared risk factors such as hypertension
rather than shared pathogenesis.
This study has several strengths. The sample size was large and all lacunar strokes were confirmed by
MRI, reducing the possibility of misclassification which might occur when using CT. In addition, the
design of the study, which made use of genetic data, means that the results are less susceptible to the
residual confounding and reverse causation that observational studies can suffer from, although other
sources of confounding, such as technical artifacts, may arise. Similarly, this study has weaknesses. We
were unable to evaluate 3 rare SNPs which were associated with WMH in the previous publication,
which may have affected our results. Some lacunar infarcts were diagnosed as acute lesions on DWI,
but others were diagnosed from MRI scans performed after the acute stroke phase as cavities on T1 or
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fluid-attenuated inversion recovery images. The inclusion of patients defined using these different
radiological criteria may introduce a subtle bias, and it is possible that some of these cavities could have
resulted from hemorrhage rather than ischemia. Although MRI was performed for all lacunar stroke
subjects, it was not performed in all nonlacunar subtypes, which could lead to some degree of
misclassification. In addition, controls were historical and MRI was not performed to rule out
cerebrovascular disease.
Conclusions
Genetic factors that affect WMH are also associated with risk of lacunar stroke, but not other stroke
subtypes. This sheds new light on processes that are implicated in lacunar stroke and provides further
evidence that shared pathophysiological processes underlie different manifestations of SVD.
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